M RIEWOLDT HOLDINGS LIMITED
About
Maddie Riewoldt's Vision (M Riewoldt Holdings Limited) is a charitable foundation dedicated to funding research to discover cures for Bone Marrow Failure Syndromes. Founded in 2015 following Maddie Riewoldt's death from Aplastic Anaemia at age 26, the foundation supports medical research projects and provides patient and family support services including a Tele-Support Service and Peer Support Program. The foundation operates nationally across Australia with an annual giving of approximately $1.57 million.
Tips for Applicants
Focus applications on specific Bone Marrow Failure Syndromes research - they have clearly defined priority areas including clinical trials, genomic evaluation, and transplant outcomes. Review their existing funded research projects to understand their interests, and emphasise potential for breakthroughs and leveraged funding.
Giving Philosophy
The foundation funds high-impact medical research projects focused on understanding, treating and curing Bone Marrow Failure Syndromes. It selects research projects that show potential for breakthroughs and also provides direct support services to patients and families affected by these conditions. The foundation values leveraging additional funding and collaboration with research institutions.
ACNC Financial History
| Year | Grants Given | Revenue | Total Assets | Net Assets |
|---|---|---|---|---|
| FY2023 | $1.5M | $1.9M | $3.7M | $3.3M |
| FY2022 | $1.4M | $3.0M | $4.7M | $3.5M |
| FY2021 | $1.6M | $1.6M | $4.1M | $2.4M |
| FY2020 | $1.5M | $2.1M | $4.6M | $3.0M |
| FY2019 | $228K | $579K | $3.3M | $2.6M |
| 5yr total | $6.1M | Source: ACNC Annual Information Statements | ||